Mar 10, 2020
Correvio Partners with Hong Kong Teson Pharma Limited for the Commercialization of Aggrastat® in China
Mar 04, 2020
Cardiac Biomarkers - An Essential Tool in the Diagnosis and Management of Cardiovascular Diseases: Infinium Global Research
Jan 30, 2020
Genetesis Pilot study: 90-second scan shows promise in evaluating chest pain patients in Emergency Department observation unit
Oct 21, 2019
Trial findings contradict established acute coronary syndrome recommendations for depression screening
Sep 03, 2019
The European Society of Cardiology Includes Neovasc Reducer(TM) for the Treatment of Refractory Angina in the European Practice Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes
Jun 13, 2019
Cardiac Biomarkers Testing Market to Reach $18.23 Bn, Globally, by 2026 at 11.4% CAGR: Allied Market Research
Jun 06, 2018
Western European Cardiac Troponin Diagnostics Market to 2021
May 25, 2018
Getinge announces results from SEMPER FI pilot study of intra-aortic balloon pump showing numerical trend toward reduced mortality in patients with extensive myocardial infarction and persistent ischemia
May 23, 2018
CeloNova Announces Positive Clinical Results of eCOBRA Study at EuroPCR 2018
Mar 23, 2018
CSL Behring Announces First Patient Enrollment in Phase 3 Clinical Trial of CSL112 to Assess Reduction of Early Recurrent Cardiovascular Events in Heart Attack Survivors
Feb 28, 2018
Study shows high-sensitivity cardiac troponin I concentration, measured with the Singulex cTnI assay, is an independent predictor of obstructive coronary artery disease in patients with suspected stable angina
Jan 23, 2018
Cardiome Announces Expanded Label for Aggrastat® in China Including New STEMI Indication and High Dose Bolus Regimen
Dec 12, 2017
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
Nov 16, 2017
Global Acute Coronary Syndrome Epidemiology and Patient Flow Analysis - 2017
Sep 08, 2017
Singulex Receives New, Broad Patent For Digital Detection Of Cardiac Troponin-I Or Cardiac Troponin-T For Coronary Artery Disease Rule-Out
Aug 01, 2017
Evaluations of the Analytical Performance of the Singulex Cardiac Troponin I Assay Used on its Single Molecule Counting Technology Platform Demonstrates Ability to Improve Cardiovascular Disease Rule-Out